Skip to main content
NCBI home page
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1985;20(Suppl 2):289S–295S. doi: 10.1111/j.1365-2125.1985.tb02815.x

Clinical studies with calcium antagonists in asthma

P J Barnes
PMCID: PMC1400645  PMID: 3902071

Full text

PDF
289S

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barnes P. J. Calcium-channel blockers and asthma. Thorax. 1983 Jul;38(7):481–485. doi: 10.1136/thx.38.7.481. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Barnes P. J. Pathogenesis of asthma: a review. J R Soc Med. 1983 Jul;76(7):580–586. doi: 10.1177/014107688307600711. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Barnes P. J., Wilson N. M., Brown M. J. A calcium antagonist, nifedipine, modifies exercise-induced asthma. Thorax. 1981 Oct;36(10):726–730. doi: 10.1136/thx.36.10.726. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Brugman T. M., Darnell M. L., Hirshman C. A. Nifedipine aerosol attenuates airway constriction in dogs with hyperreactive airways. Am Rev Respir Dis. 1983 Jan;127(1):14–17. doi: 10.1164/arrd.1983.127.1.14. [DOI] [PubMed] [Google Scholar]
  5. Cerrina J., Denjean A., Alexandre G., Lockhart A., Duroux P. Inhibition of exercise-induced asthma by a calcium antagonist, nifedipine. Am Rev Respir Dis. 1981 Feb;123(2):156–160. doi: 10.1164/arrd.1981.123.2.156. [DOI] [PubMed] [Google Scholar]
  6. Cheng J. B., Townley R. G. Pharmacological characterization of effects of nifedipine on isolated guinea-pig and rat tracheal smooth muscle. Arch Int Pharmacodyn Ther. 1983 Jun;263(2):228–244. [PubMed] [Google Scholar]
  7. Coburn R. F. The airway smooth muscle cell. Fed Proc. 1977 Dec;36(13):2692–2697. [PubMed] [Google Scholar]
  8. Corris P. A., Nariman S., Gibson G. J. Nifedipine in the prevention of asthma induced by exercise and histamine. Am Rev Respir Dis. 1983 Dec;128(6):991–992. doi: 10.1164/arrd.1983.128.6.991. [DOI] [PubMed] [Google Scholar]
  9. Creese B. R., Denborough M. A. Sources of calcium for contraction of guinea-pig isolated tracheal smooth muscle. Clin Exp Pharmacol Physiol. 1981 Mar-Apr;8(2):175–182. doi: 10.1111/j.1440-1681.1981.tb00149.x. [DOI] [PubMed] [Google Scholar]
  10. Drazen J. M., Fanta C. H., Lacouture P. G. Effect of nifedipine on constriction of human tracheal strips in vitro. Br J Pharmacol. 1983 Apr;78(4):687–691. doi: 10.1111/j.1476-5381.1983.tb09421.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Drouet N. Mobile medical emergency units in France-part II. Br Med J (Clin Res Ed) 1982 Jun 26;284(6333):1926–1928. doi: 10.1136/bmj.284.6333.1926. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Fanta C. H., Drazen J. M. Calcium blockers and bronchoconstriction. Am Rev Respir Dis. 1983 Jun;127(6):673–674. doi: 10.1164/arrd.1983.127.6.673. [DOI] [PubMed] [Google Scholar]
  13. Fanta C. H., Venugopalan C. S., Lacouture P. G., Drazen J. M. Inhibition of bronchoconstriction in the guinea pig by a calcium channel blocker, nifedipine. Am Rev Respir Dis. 1982 Jan;125(1):61–66. doi: 10.1164/arrd.1982.125.1.61. [DOI] [PubMed] [Google Scholar]
  14. Farley J. M., Miles P. R. The sources of calcium for acetylcholine-induced contractions of dog tracheal smooth muscle. J Pharmacol Exp Ther. 1978 Nov;207(2):340–346. [PubMed] [Google Scholar]
  15. Gonzalez J. M., Morice R. C., Bloom K., Akers S., Raizner A. E., Stevens P. M. Inhibition of airway reactivity by nifedipine in patients with coronary artery disease. Am Rev Respir Dis. 1983 Feb;127(2):155–157. doi: 10.1164/arrd.1983.127.2.155. [DOI] [PubMed] [Google Scholar]
  16. Henderson A. F., Heaton R. W., Costello J. F. Effect of nifedipine on bronchoconstriction induced by inhalation of cold air. Thorax. 1983 Jul;38(7):512–515. doi: 10.1136/thx.38.7.512. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Henderson A. F., Heaton R. W., Dunlop L. S., Costello J. F. Effects of nifedipine on antigen-induced bronchoconstriction. Am Rev Respir Dis. 1983 May;127(5):549–553. doi: 10.1164/arrd.1983.127.5.549. [DOI] [PubMed] [Google Scholar]
  18. Ind P. W., Barnes P. J., Brown M. J., Causon R., Dollery C. T. Measurement of plasma histamine in asthma. Clin Allergy. 1983 Jan;13(1):61–67. doi: 10.1111/j.1365-2222.1983.tb02568.x. [DOI] [PubMed] [Google Scholar]
  19. Jensen C., Stahl Skov P., Norn S. Inhibitory effect of calcium antagonists on histamine release from human leukocytes. In vivo and in vitro experiments. Allergy. 1983 May;38(4):233–237. doi: 10.1111/j.1398-9995.1983.tb01616.x. [DOI] [PubMed] [Google Scholar]
  20. Kitamura S., Ishihara Y. Effect of calcium antagonist, etafenone hydrochloride, on the isolated guinea pig tracheal tissues. Arzneimittelforschung. 1980;30(7):1088–1091. [PubMed] [Google Scholar]
  21. Lee V. Y., Hughes J. M., Seale J. P., Temple D. M. Verapamil inhibits mediator release from human lung in vitro. Thorax. 1983 May;38(5):386–387. doi: 10.1136/thx.38.5.386. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Lever A. M., Corris P. A., Gibson G. J. Nifedipine enhances the bronchodilator effect of salbutamol. Thorax. 1984 Aug;39(8):576–578. doi: 10.1136/thx.39.8.576. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Magnussen H., Hartmann V., Reuss G. Influence of diltiazem on bronchoconstriction induced by cold air breathing during exercise. Thorax. 1984 Aug;39(8):579–582. doi: 10.1136/thx.39.8.579. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Malo P. E., Wasserman M. A., Griffin R. L. Effects of intravenous and aerosol nifedipine on prostaglandin F2 alpha and histamine-induced bronchoconstriction in anesthetized dogs. J Pharmacol Exp Ther. 1982 May;221(2):410–415. [PubMed] [Google Scholar]
  25. McIntyre E., Fitzgibbon B., Otto H., Minson R., Alpers J., Ruffin R. Inhaled verapamil in histamine-induced bronchoconstriction. J Allergy Clin Immunol. 1983 Apr;71(4):375–381. doi: 10.1016/0091-6749(83)90065-9. [DOI] [PubMed] [Google Scholar]
  26. Miadonna A., Tedeschi A., Leggieri E., Cottini M., Restuccia M., Bianchini C. Effect of verapamil on allergen-induced asthma in patients with respiratory allergy. Ann Allergy. 1983 Aug;51(2 Pt 1):201–204. [PubMed] [Google Scholar]
  27. Middleton E., Jr Antiasthmatic drug therapy and calcium ions: review of pathogenesis and role of calcium. J Pharm Sci. 1980 Feb;69(2):243–251. doi: 10.1002/jps.2600690244. [DOI] [PubMed] [Google Scholar]
  28. Middleton E., Jr, Drzewiecki G., Triggle D. Effects of smooth muscle calcium antagonists on human basophil histamine release. Biochem Pharmacol. 1981 Oct;30(20):2867–2869. doi: 10.1016/0006-2952(81)90428-7. [DOI] [PubMed] [Google Scholar]
  29. Middleton E., Jr Role of calcium and calcium antagonists in airway function. Eur J Respir Dis Suppl. 1983;128(Pt 1):123–132. [PubMed] [Google Scholar]
  30. Murphy K. M., Gould R. J., Largent B. L., Snyder S. H. A unitary mechanism of calcium antagonist drug action. Proc Natl Acad Sci U S A. 1983 Feb;80(3):860–864. doi: 10.1073/pnas.80.3.860. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Patakas D., Vlachoianni E., Tsara V., Louridas G., Argiropoulou P. Nifedipine in bronchial asthma. J Allergy Clin Immunol. 1983 Sep;72(3):269–273. doi: 10.1016/0091-6749(83)90031-3. [DOI] [PubMed] [Google Scholar]
  32. Patel K. R., Al Shama M. R., Kerr J. W. The effect of inhaled verapamil on allergen-induced bronchoconstriction. Clin Allergy. 1983 Mar;13(2):119–122. doi: 10.1111/j.1365-2222.1983.tb02578.x. [DOI] [PubMed] [Google Scholar]
  33. Patel K. R. Calcium antagonists in exercise-induced asthma. Br Med J (Clin Res Ed) 1981 Mar 21;282(6268):932–933. doi: 10.1136/bmj.282.6268.932. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Patel K. R. The effect of calcium antagonist, nifedipine in exercise-induced asthma. Clin Allergy. 1981 Sep;11(5):429–432. doi: 10.1111/j.1365-2222.1981.tb01615.x. [DOI] [PubMed] [Google Scholar]
  35. Patel K. R. The effect of verapamil on histamine and methacholine-induced bronchoconstriction. Clin Allergy. 1981 Sep;11(5):441–447. doi: 10.1111/j.1365-2222.1981.tb01617.x. [DOI] [PubMed] [Google Scholar]
  36. Russi E. W., Marchette B., Yerger L., Abraham W. M., Ahmed T. Modification of allergic bronchoconstriction by a calcium antagonist: mode of action. Am Rev Respir Dis. 1983 Jun;127(6):675–679. doi: 10.1164/arrd.1983.127.6.675. [DOI] [PubMed] [Google Scholar]
  37. Secher C., Brofeldt S., Mygind N. Intranasal verapamil in allergen-induced rhinitis. Allergy. 1983 Nov;38(8):565–570. doi: 10.1111/j.1398-9995.1983.tb04141.x. [DOI] [PubMed] [Google Scholar]
  38. Smith R. D. Calcium entry blockers: key issues. Fed Proc. 1983 Feb;42(2):201–206. [PubMed] [Google Scholar]
  39. So S. Y., Lam W. K., Yu D. Y. Effect of calcium antagonists on allergen-induced asthma. Clin Allergy. 1982 Nov;12(6):595–600. doi: 10.1111/j.1365-2222.1982.tb02558.x. [DOI] [PubMed] [Google Scholar]
  40. Svedmyr K., Löfdahl C. G., Svedmyr N. Nifedipine--a calcium channel blocker--in asthmatic patients. Interaction with terbutaline. Allergy. 1984 Jan;39(1):17–22. doi: 10.1111/j.1398-9995.1984.tb01928.x. [DOI] [PubMed] [Google Scholar]
  41. Walters E. H., Banks J., Fennerty A., Davies B. H. Effects of calcium channel blockade on histamine induced bronchoconstriction in mild asthma. Thorax. 1984 Aug;39(8):572–575. doi: 10.1136/thx.39.8.572. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Williams D. O., Barnes P. J., Vickers H. P., Rudolf M. Effect of nifedipine on bronchomotor tone and histamine reactivity in asthma. Br Med J (Clin Res Ed) 1981 Aug 1;283(6287):348–348. doi: 10.1136/bmj.283.6287.348. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES